Benzalkonium chloride foruse in treating conjunctivitis and/or covid-19
AssigneeBausch + Lomb Ireland Limited
InventorsPatrick McCormick, Kimberly Millard
Life of this patent
Estimating the term…
Abstract
Methods for treating coronavirus disease 2019 (COVID-19), including at least one ocular manifestation of COVID-19, methods for treating conjunctivitis, and methods for reducing COVID-19 transmission comprising administering an effective amount of benzalkonium chloride are disclosed. Pharmaceutical compositions comprising benzalkonium chloride are also disclosed.
Claims40
A method for treating at least one ocular manifestation of coronavirus disease 2019 (COVID-19) comprising administering to a subject in need thereof a pharmaceutical composition comprising an effective amount of benzalkonium chloride, pheniramine maleate, and naphazoline HCl.
A method for reducing a risk of SARS-COV-2 ocular transmission comprising administering to a subject in need thereof a pharmaceutical composition comprising an effective amount of benzalkonium chloride, pheniramine maleate, and naphazoline HCl.
A method for preventing coronavirus disease 2019 (COVID-19) comprising administering to a subject in need thereof a pharmaceutical composition comprising an effective amount of benzalkonium chloride, pheniramine maleate, and naphazoline HCl.
A method for reducing an ocular SARS-COV-2 viral load comprising administering to a subject in need thereof a pharmaceutical composition comprising an effective amount of benzalkonium chloride, pheniramine maleate, and naphazoline HCl.
A method for reducing an intranasal SARS-COV-2 viral load comprising administering to a subject in need thereof a pharmaceutical composition comprising an effective amount of benzalkonium chloride, pheniramine maleate, and naphazoline HCl.
The method of 29, wherein the pharmaceutical composition is the form of a spray.
A method for treating or preventing coronavirus disease 2019 (COVID-19) comprising intranasally administering to a subject in need thereof a pharmaceutical composition comprising an effective amount of benzalkonium chloride, pheniramine maleate, and naphazoline HCl.
Dependencies are inferred from the claim text.